Literature DB >> 16941143

Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.

Chrysanthos Symeonidis1, Eudoxia Diza, Eleni Papakonstantinou, Efimia Souliou, George Karakiulakis, Stavros A Dimitrakos.   

Abstract

BACKGROUND: We investigated the activity of matrix metalloproteinase (MMP)-2 and -9 and the protein levels of MMP-1, -3, -8 and the tissue inhibitor of MMPs (TIMP)-1 in the subretinal fluid (SRF) of patients with rhegmatogenous retinal detachment (RRD) and establishment of potential correlations with clinical parameters.
METHODS: Thirty-seven SRF from RRD patients and nine vitreous samples from the human eye of organ donors (controls) were collected and assayed for MMP-1,-3,-8 and TIMP-1 levels using ELISA and for MMP-2 and -9 activity employing gelatin zymography.
RESULTS: MMP-1, MMP-3, MMP-8, proMMP-2, proMMP-9, MMP-9 and TIMP-1 levels were higher in SRF compared with vitreous fluid. Overall, MMPs and TIMPs were differentially expressed in SRF with respect to duration and extent of RRD, as well as to stage of proliferative vitreoretinopathy. Regression analysis for all data indicated that a model consisting of MMP-3, MMP-8 and proMMP-9 could estimate the extent of RRD.
CONCLUSIONS: MMPs and TIMP-1 levels are elevated in SRF during RRD. A regression model consisting of MMP-3, MMP-8 and proMMP-9 may be proved to be of potential use in providing information for evaluation of the extent of RRD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941143     DOI: 10.1007/s00417-006-0386-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

1.  Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1.

Authors:  B E Bachmeier; A G Nerlich; P Boukamp; R Lichtinghagen; H Tschesche; H Fritz; E Fink
Journal:  Biol Chem       Date:  2000 May-Jun       Impact factor: 3.915

Review 2.  Matrix metalloproteinases in disease and repair processes in the anterior segment.

Authors:  Tina T L Wong; Charanjit Sethi; Julie T Daniels; G Astrid Limb; Gillian Murphy; Peng T Khaw
Journal:  Surv Ophthalmol       Date:  2002 May-Jun       Impact factor: 6.048

Review 3.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

Review 4.  Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.

Authors:  P Borden; R A Heller
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1997       Impact factor: 1.807

5.  TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function.

Authors:  M A Behzadian; X L Wang; L J Windsor; N Ghaly; R B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

6.  Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.

Authors:  Sergiu T Leu; Suchitra Batni; Monte J Radeke; Lincoln V Johnson; Don H Anderson; Dennis O Clegg
Journal:  Exp Eye Res       Date:  2002-01       Impact factor: 3.467

7.  Role of retinal detachment subretinal fluid on extracellular matrix metabolism.

Authors:  Georgina González-Avila; David Méndez; David Lozano; Carlos Ramos; Javier Delgado; Cecilia Iturria
Journal:  Ophthalmologica       Date:  2004 Jan-Feb       Impact factor: 3.250

8.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

9.  Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization.

Authors:  Mohammed El Bradey; Lingyun Cheng; Dirk-Uwe Bartsch; Krzystof Appelt; Nuttawut Rodanant; Germaine Bergeron-Lynn; William R Freeman
Journal:  J Ocul Pharmacol Ther       Date:  2004-06       Impact factor: 2.671

10.  Gelatinase B in proliferative vitreoretinal disorders.

Authors:  A M Abu El-Asrar; L Dralands; M Veckeneer; K Geboes; L Missotten; I Van Aelst; G Opdenakker
Journal:  Am J Ophthalmol       Date:  1998-06       Impact factor: 5.258

View more
  7 in total

1.  Preservation of the structure of enzymatically-degraded bovine vitreous using synthetic proteoglycan mimics.

Authors:  Qianru Zhang; Benjamen A Filas; Robyn Roth; John Heuser; Nan Ma; Shaili Sharma; Alyssa Panitch; David C Beebe; Ying-Bo Shui
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-23       Impact factor: 4.799

2.  Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.

Authors:  Bongsu Kim; Mohamed H Abdel-Rahman; Tiffany Wang; Severin Pouly; Ashraf M Mahmoud; Colleen M Cebulla
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-03       Impact factor: 4.799

3.  Photoreceptor disruption related to persistent submacular fluid after successful scleral buckle surgery.

Authors:  Se Joon Woo; Kyoung Min Lee; Hum Chung; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2011-11-22

4.  Sequential in-office vitreous aspirates demonstrate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration.

Authors:  Stephanie M Ecker; Scott M Pfahler; Joshua C Hines; Ann S Lovelace; Bert M Glaser
Journal:  Mol Vis       Date:  2012-06-20       Impact factor: 2.367

5.  Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells.

Authors:  Ryo Matoba; Yuki Morizane; Yusuke Shiode; Masayuki Hirano; Shinichiro Doi; Shinji Toshima; Ryoichi Araki; Mika Hosogi; Tomoko Yonezawa; Fumio Shiraga
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

Review 6.  Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).

Authors:  Luis García-Onrubia; Fco Javier Valentín-Bravo; Rosa M Coco-Martin; Rogelio González-Sarmiento; J Carlos Pastor; Ricardo Usategui-Martín; Salvador Pastor-Idoate
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 7.  Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases.

Authors:  Fátima Milhano Santos; Joana Mesquita; João Paulo Castro-de-Sousa; Sergio Ciordia; Alberto Paradela; Cândida Teixeira Tomaz
Journal:  Antioxidants (Basel)       Date:  2022-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.